首页 正文

Febrile neutropenia in patients treated with chemotherapy/immune checkpoint inhibition: a MASCC consensus statement

{{output}}
Chemotherapy/immune checkpoint inhibitor (ICI) therapy is increasingly standard of care for a range of cancers. Increasing numbers of emergency cancer presentations mean alternative pathways are required to ensure sustainable services and improve outcomes. Feb... ...